We have previously shown that GLP-1 (9-36) administration enhances neuronal plasticity in young WT mice and ameliorates cognitive deficits in a mouse model of Alzheimer’s disease. This evidence concerns the gene GCG and early-onset autosomal dominant Alzheimer disease.